ChemicalBook--->CAS DataBase List--->1431641-29-0

1431641-29-0

1431641-29-0 Structure

1431641-29-0 Structure
IdentificationBack Directory
[Name]

ADX71743
[CAS]

1431641-29-0
[Synonyms]

ADX71743
ADX71743 >=98% (HPLC)
[Molecular Formula]

C17H19NO2
[MDL Number]

MFCD30474715
[MOL File]

1431641-29-0.mol
[Molecular Weight]

269.34
Chemical PropertiesBack Directory
[Boiling point ]

405.1±24.0 °C(Predicted)
[density ]

1.130±0.06 g/cm3(Predicted)
[storage temp. ]

-20°C
[solubility ]

DMSO: 5mg/mL, clear (warmed)
[form ]

powder
[pka]

-0.05±0.40(Predicted)
[color ]

white to beige
Hazard InformationBack Directory
[Uses]

(±)-ADX 71743 is a potent and selective negative allosteric modulator of metabotropic glutamate receptor 7 mGlu7.
[Biological Activity]

ADX71743 is a brain-penetrantselective and potent negative allosteric modulator of metabotropic glutamate receptor 7 (mGlu7). In one study ADX71743 exhibited an anxiolytic-like profile in r at and mouse models without causing impairment of locomotor activity. In another study it induced absence epileptic seizures and lethargy.''ADX71743 is known to negatively regulate the effect of mGlu7 (metabotropic glutamate receptor subtype 7)which is associated with a number of anxiety disorders.
[Enzyme inhibitor]

This brain-penetrant mGlu7 allosteric negative modulator (FW = 269.34 g/mol; CAS 1431641-29-0; Solubility: 100 mM in DMSO), also named 6- (2,4-dimethylphenyl)-2-ethyl-6,7-dihydro-4(5H)-benzoxazolone, potently and selectively targets the metabotropic glutamate receptor-7, itself a promising novel target for treatment of anxiety, post-traumatic stress disorder, depression, drug abuse, and schizophrenia. When tested in vitro, Schild plot analysis and reversibility tests at the target confirmed the NAM properties of the compound and attenuation of L-(+)-2-amino-4- phosphonobutyric acid (or L-AP4) -induced synaptic depression confirmed activity at the native receptor. When tested in vitro, ADX-71743 gives a IC50 value versus EC80 of glutamate = 22 nM at human mGlu7 in a 3’,5’- cyclic-AMP assay, with IC50 values versus EC80 of L-AP4 are 63 and 125 nM at human mGlu7 in Ca2+ and cAMP assays respectively; IC50 value versus EC80 of L-AP4 = 88 nM at rmGlu7 in a Ca2+assay). Selective for mGlu7 over all other mGlu receptor subtypes and a panel of relevant GPCRs. Exhibits an anxiolytic-like profile in vivo. The Schild plot experiments clearly indicate the noncompetitive nature of ADX71743 inhibition, whereas simple wash experiments seem to indicate that its binding to the receptor is readily reversible. Other Targets: When tested for its action at other mGlu-expressing cells in series of FLIPR experiments, ADX71743 showed no detectable activity (either agonist or allosteric effects) in cell lines expressing hmGlu3, hmGlu4, rmGlu5, hmGlu6, and hmGlu8. A negligible inhibition of rmGlu1 (32% at 30 μM) and a weak positive allosteric modulator effect on hmGlu2 (EC50 = 11 μM) was measured. When further tested in a functional GPCR screen against 27 targets in agonist and antagonist modes, ADX71743 exhibited no stimulation or inhibition above 27% was observed.
[in vivo]

ADX71743 (50, 100, 150 mg/kg; SC) results in robust reductions in numbers of buried marbles to near maximal levels at lower doses (50 and 100 mg/kg)[2].
ADX71743 (12.5, 100 mg/kg for mice and 100 mg/kg for rat; SC) has a T1/2 of 0.68, 0.40 hours, a Cmax of 1380, 12766 ng/ml of 12.5 mg/kg and 100 mg/kg in mice[2].

Animal Model:Adult male C57Bl6/J mice (24-30 g)[2]
Dosage:50, 100, 150 mg/kg
Administration:SC
Result:Resulted in robust reductions in numbers of buried marbles to near maximal levels at lower doses (50 and 100 mg/kg).
Animal Model:Adult male C57Bl6/J mice (24-30 g) and Sprague-Dawley rats (250-350 g)[2]
Dosage:12.5, 100 mg/kg for mice and 100 mg/kg for rat (Pharmacokinetic Analysis)
Administration:SC
Result:Had a T1/2 of 0.68, 0.40 hours, a Cmax of 1380, 12766 ng/ml of 12.5 mg/kg and 100 mg/kg in mice.
Had a T1/2 of 1.5 hours, a Cmax of 16800 ng/ml of 100 mg/kg in rat.
[IC 50]

mGlu7
1431641-29-0 suppliers list
Company Name: TargetMol Chemicals Inc.
Tel: +1-781-999-5354 +1-00000000000 , +1-00000000000
Website: https://www.targetmol.com/
Company Name: TargetMol Chemicals Inc.
Tel: +8613564774135 , +8613564774135
Website:
Company Name: Shanghai Hongye Biotechnology Co. Ltd  
Tel: 400-9205774
Website: www.glpbio.cn
Company Name: BOC Sciences  
Tel:
Website: https://www.bocsci.com
Company Name: Energy Chemical  
Tel: 021-58432009 400-005-6266
Website: http://www.energy-chemical.com
Company Name: Changzhou Furuisi Biotechnology Co., Ltd  
Tel: 0519-85524369
Website: www.chemicalbook.com/ShowSupplierProductsList1441214/0.htm
Company Name: Beijing Jin Ming Biotechnology Co., Ltd.  
Tel: 010-60605840 15801484223;
Website: http://www.jm-bio.com/
Company Name: Nantong QuanYi Biotechnology Co., Ltd  
Tel: 0513-66337626 18051384581
Website: https://www.chemhifuture.com/
Company Name: TargetMol Chemicals Inc.  
Tel: 15002134094
Website: https://www.targetmol.cn/
Company Name: R&D Systems, Inc  
Tel: 18003437475 18003437475
Website: www.rndsystems.com
Company Name: Merck KGaA  
Tel: 21-20338288
Website: www.sigmaaldrich.cn
Company Name: Biosynth Biological Technology (Suzhou) Co Ltd  
Tel: 51288865780
Website: www.biosynth.com
Company Name: MedChemExpress  
Tel: 021-58955995
Website: www.medchemexpress.com
Tags:1431641-29-0 Related Product Information

  • HomePage | Member Companies | Advertising | Contact us | Previous WebSite | MSDS | CAS Index | CAS DataBase | Privacy | Terms | About Us
  • All products displayed on this website are only for non-medical purposes such as industrial applications or scientific research, and cannot be used for clinical diagnosis or treatment of humans or animals. They are not medicinal or edible.
    According to relevant laws and regulations and the regulations of this website, units or individuals who purchase hazardous materials should obtain valid qualifications and qualification conditions.
  • Copyright © 2023 ChemicalBook All rights reserved.